AnaptysBio (ANAB) 8-K Summary

Event: AnaptysBio filed an 8-K on November 4, 2025, reporting financial results.

• Item 2.02 details the release of earnings for the three and nine months ended September 30, 2025.
• Financial specifics are contained in Exhibit 99.1, the accompanying press release.

Note: This filing serves as notification; investors must consult Exhibit 99.1 for concrete financial metrics and performance data.

• Important Disclaimer: Information in this Item 2.02 and Exhibit 99.1 is generally not deemed “filed” for liability purposes under Secti